229 related articles for article (PubMed ID: 27259980)
1. Immunoregulatory roles of versican proteolysis in the myeloma microenvironment.
Hope C; Foulcer S; Jagodinsky J; Chen SX; Jensen JL; Patel S; Leith C; Maroulakou I; Callander N; Miyamoto S; Hematti P; Apte SS; Asimakopoulos F
Blood; 2016 Aug; 128(5):680-5. PubMed ID: 27259980
[TBL] [Abstract][Full Text] [Related]
2. Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.
Hope C; Emmerich PB; Papadas A; Pagenkopf A; Matkowskyj KA; Van De Hey DR; Payne SN; Clipson L; Callander NS; Hematti P; Miyamoto S; Johnson MG; Deming DA; Asimakopoulos F
J Immunol; 2017 Sep; 199(5):1933-1941. PubMed ID: 28754680
[TBL] [Abstract][Full Text] [Related]
3. TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
Hope C; Ollar SJ; Heninger E; Hebron E; Jensen JL; Kim J; Maroulakou I; Miyamoto S; Leith C; Yang DT; Callander N; Hematti P; Chesi M; Bergsagel PL; Asimakopoulos F
Blood; 2014 May; 123(21):3305-15. PubMed ID: 24723682
[TBL] [Abstract][Full Text] [Related]
4. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling.
Gupta N; Kumar R; Seth T; Garg B; Sharma A
RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704
[TBL] [Abstract][Full Text] [Related]
5. Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment.
Papadas A; Deb G; Cicala A; Officer A; Hope C; Pagenkopf A; Flietner E; Morrow ZT; Emmerich P; Wiesner J; Arauz G; Bansal V; Esbona K; Capitini CM; Matkowskyj KA; Deming DA; Politi K; Abrams SI; Harismendy O; Asimakopoulos F
Cell Rep; 2022 Aug; 40(7):111201. PubMed ID: 35977482
[TBL] [Abstract][Full Text] [Related]
6. Versican in the Tumor Microenvironment.
Papadas A; Asimakopoulos F
Adv Exp Med Biol; 2020; 1272():55-72. PubMed ID: 32845502
[TBL] [Abstract][Full Text] [Related]
7. A new mouse mutant with cleavage-resistant versican and isoform-specific versican mutants demonstrate that proteolysis at the Glu
Nandadasa S; Burin des Roziers C; Koch C; Tran-Lundmark K; Dours-Zimmermann MT; Zimmermann DR; Valleix S; Apte SS
Matrix Biol Plus; 2021 Jun; 10():100064. PubMed ID: 34195596
[TBL] [Abstract][Full Text] [Related]
8. The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis.
Nandadasa S; Foulcer S; Apte SS
Matrix Biol; 2014 Apr; 35():34-41. PubMed ID: 24444773
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling.
Gupta N; Kumar R; Sharma A
Mol Cell Biochem; 2021 Jun; 476(6):2551-2559. PubMed ID: 33649985
[TBL] [Abstract][Full Text] [Related]
10. Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis.
Asano K; Nelson CM; Nandadasa S; Aramaki-Hattori N; Lindner DJ; Alban T; Inagaki J; Ohtsuki T; Oohashi T; Apte SS; Hirohata S
Sci Rep; 2017 Dec; 7(1):17225. PubMed ID: 29222454
[TBL] [Abstract][Full Text] [Related]
11. Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma.
Dhakal B; Pagenkopf A; Mushtaq MU; Cunningham AM; Flietner E; Morrow Z; Papadas A; Hope C; Leith C; Hematti P; Hari P; Callander NS; Asimakopoulos F
Leuk Lymphoma; 2019 Oct; 60(10):2558-2562. PubMed ID: 30845856
[No Abstract] [Full Text] [Related]
12. The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.
Mougiakakos D; Bach C; Böttcher M; Beier F; Röhner L; Stoll A; Rehli M; Gebhard C; Lischer C; Eberhardt M; Vera J; Büttner-Herold M; Bitterer K; Balzer H; Leffler M; Jitschin S; Hundemer M; Awwad MHS; Busch M; Stenger S; Völkl S; Schütz C; Krönke J; Mackensen A; Bruns H
Cancer Immunol Res; 2021 Mar; 9(3):265-278. PubMed ID: 33563611
[TBL] [Abstract][Full Text] [Related]
13. Versican and its associated molecules: potential diagnostic markers for multiple myeloma.
Gupta N; Khan R; Kumar R; Kumar L; Sharma A
Clin Chim Acta; 2015 Mar; 442():119-24. PubMed ID: 25623955
[TBL] [Abstract][Full Text] [Related]
14. Context-dependent bioactivity of versican fragments.
Timms KP; Maurice SB
Glycobiology; 2020 May; 30(6):365-373. PubMed ID: 31651027
[TBL] [Abstract][Full Text] [Related]
15. ADAMTS4 is a crucial proteolytic enzyme for versican cleavage in the amnion at parturition.
Li MD; Lu JW; Zhang F; Lei WJ; Pan F; Lin YK; Ling LJ; Myatt L; Wang WS; Sun K
Commun Biol; 2024 Mar; 7(1):301. PubMed ID: 38461223
[TBL] [Abstract][Full Text] [Related]
16. Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate.
Hirani P; McDermott J; Rajeeve V; Cutillas PR; Jones JL; Pennington DJ; Wight TN; Santamaria S; Alonge KM; Pearce OMT
Cancer Res Commun; 2024 Apr; 4(4):970-985. PubMed ID: 38517140
[TBL] [Abstract][Full Text] [Related]
17. Determination of Versikine Levels by Enzyme-Linked Immunosorbent Assay (ELISA).
Minns AF; Santamaria S
Methods Mol Biol; 2024; 2747():83-93. PubMed ID: 38038934
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles.
McRae N; Forgan L; McNeill B; Addinsall A; McCulloch D; Van der Poel C; Stupka N
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211034
[TBL] [Abstract][Full Text] [Related]
19. Deletion of ADAMTS5 does not affect aggrecan or versican degradation but promotes glucose uptake and proteoglycan synthesis in murine adipose derived stromal cells.
Gorski DJ; Xiao W; Li J; Luo W; Lauer M; Kisiday J; Plaas A; Sandy J
Matrix Biol; 2015 Sep; 47():66-84. PubMed ID: 25840345
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma.
Gupta N; Kumar R; Seth T; Garg B; Sati HC; Sharma A
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1601-1611. PubMed ID: 30891618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
